SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Amedisys, Inc. (AMED) trades at a trailing P/E of 77.1, forward P/E of 19.6. Trailing earnings yield is 1.30%, forward earnings yield 5.12%. PEG 0.07 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (57/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 19.6 (down from trailing 77.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.30% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.12% as earnings recover.
- Analyst consensus target $143.38 (+42% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 60/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
57/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AMED
Valuation Multiples
P/E (TTM)77.1
Forward P/E19.6
PEG Ratio0.07
Forward PEG0.07
P/B Ratio0.00
P/S Ratio1.42
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.31
Forward EPS (Est.)$5.17
Book Value / Share$0.00
Revenue / Share$71.05
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.30%
Forward Earnings Yield5.12%
Dividend Yield0.00%
Analyst Target$143.38 (+42%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.09 |
$1.28B |
$-3.02M |
-0.2% |
| 2016 |
$1.10 |
$1.44B |
$37.26M |
2.6% |
| 2017 |
$0.88 |
$1.53B |
$30.3M |
2% |
| 2018 |
$3.55 |
$1.66B |
$119.35M |
7.2% |
| 2019 |
$3.84 |
$1.96B |
$126.83M |
6.5% |
| 2020 |
$5.52 |
$2.07B |
$183.61M |
8.9% |
| 2021 |
$6.34 |
$2.21B |
$209.07M |
9.4% |
| 2022 |
$3.63 |
$2.22B |
$118.61M |
5.3% |
| 2023 |
$-0.30 |
$2.24B |
$-9.75M |
-0.4% |
| 2024 |
$1.31 |
$2.35B |
$43.23M |
1.8% |
